Login / Signup
Gerhard Stadlmayr
ORCID
Publication Activity (10 Years)
Years Active: 2022-2022
Publications (10 Years): 1
Top Topics
Hodgkin Lymphoma
Cell Death
Monoclonal Antibody
Nk Cells
Top Venues
International journal of molecular sciences
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Katharina Stadlbauer
,
Peter Andorfer
,
Gerhard Stadlmayr
,
Florian Rüker
,
Gordana Wozniak-Knopp
Bispecific mAb 2 Antibodies Targeting CD59 Enhance the Complement-Dependent Cytotoxicity Mediated by Rituximab.
International journal of molecular sciences
23 (9) (2022)